Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Recent & Breaking News (TSX:SVA)

Sernova Announces AGM Voting Results

TheNewsWire 3 days ago

Sernova Provides Organizational Update

TheNewsWire 9 days ago

Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for its Board of Directors

TheNewsWire 12 days ago

Sernova Provides Positive Clinical and Platform Portfolio Update

TheNewsWire April 2, 2024

Sernova Announces Management Developments

TheNewsWire March 11, 2024

Sernova Provides Recap of 2023 Accomplishments and Anticipated 2024 Milestones

TheNewsWire January 29, 2024

Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA

GlobeNewswire November 27, 2023

Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System(TM) at the 2023 IPITA-IXA-CTRMS Joint Congress

GlobeNewswire October 30, 2023

Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System(TM) for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress

GlobeNewswire October 27, 2023

Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress

GlobeNewswire October 11, 2023

Sernova Presents Compelling New Data on the Cell Pouch System(TM) as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting

GlobeNewswire September 29, 2023

Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22

GlobeNewswire September 14, 2023

Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update

GlobeNewswire September 13, 2023

Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device

GlobeNewswire September 7, 2023

Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO

GlobeNewswire September 5, 2023

Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer

GlobeNewswire July 26, 2023

Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System(TM) at American Diabetes Association 83rd Scientific Sessions

GlobeNewswire June 26, 2023

Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System(TM) During Oral Presentation at American Diabetes Association 83rd Scientific Sessions

GlobeNewswire June 22, 2023

Sernova to Participate in Upcoming Truist Securities Cell Therapy Symposium

GlobeNewswire June 16, 2023

Sernova Announces Executive Alignment and Appoints New Board Chair

GlobeNewswire May 31, 2023